Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ $211.58)
- $211.58 P/E (TTM): 20.27X Cap: $509.75B
- View JNJ Profile
- View Questions on JNJ

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Johnson & Johnson (JNJ $211.58)
- $211.58 P/E (TTM): 20.27X Cap: $509.75B
- View JNJ Profile
- View Questions on JNJ
Procter & Gamble Company (The) (PG $142.84)
- $142.84 P/E (TTM): 20.55X Cap: $333.77B
- View PG Profile
- View Questions on PG

Q: trying to decide between these two companies. PG does seem to have negative momentum. Is there more upside in PG or do you prefer JNJ or equal amounts of both?

Thanks Dave

Read Answer Asked by Dave on December 02, 2025

Amgen Inc. (AMGN $317.74)
- $317.74 P/E (TTM): 24.51X Cap: $171.09B
- View AMGN Profile
- View Questions on AMGN
CVS Health Corporation (CVS $79.42)
- $79.42 P/E (TTM): 212.71X Cap: $102.60B
- View CVS Profile
- View Questions on CVS
Johnson & Johnson (JNJ $211.58)
- $211.58 P/E (TTM): 20.27X Cap: $509.75B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $99.87)
- $99.87 P/E (TTM): 27.56X Cap: $128.03B
- View MDT Profile
- View Questions on MDT
Moderna Inc. (MRNA $29.46)
- $29.46 Cap: $11.50B
- View MRNA Profile
- View Questions on MRNA

Q: I am building a diversified portfolio of healthcare stocks. I own JNJ, AMGN, MDT, CVS and MRNA. These are 2.9%, 3.8%, 2.5%, 4% and 0.5% of my portfolio respectively. Is this a high quality portfolio? Would you recommend any changes?

Read Answer Asked by David on October 08, 2025

Amgen Inc. (AMGN $317.74)
- $317.74 P/E (TTM): 24.51X Cap: $171.09B
- View AMGN Profile
- View Questions on AMGN
Gilead Sciences Inc. (GILD $120.40)
- $120.40 P/E (TTM): 19.07X Cap: $149.37B
- View GILD Profile
- View Questions on GILD
AbbVie Inc. (ABBV $223.32)
- $223.32 P/E (TTM): 107.17X Cap: $394.69B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $125.46)
- $125.46 P/E (TTM): 15.47X Cap: $214.36B
- View ABT Profile
- View Questions on ABT
The Cigna Group (CI $274.70)
- $274.70 P/E (TTM): 12.07X Cap: $73.37B
- View CI Profile
- View Questions on CI
Johnson & Johnson (JNJ $211.58)
- $211.58 P/E (TTM): 20.27X Cap: $509.75B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $99.87)
- $99.87 P/E (TTM): 27.56X Cap: $128.03B
- View MDT Profile
- View Questions on MDT
Savaria Corporation (SIS $21.83)
- $21.83 P/E (TTM): 25.41X Cap: $1.56B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: I am mostly content with my health care stocks with the exception of MDT. It has been essentially flat since about 2016 except for the dividend. It did peak around 2022 but has fallen down to previous levels.
What do you think of the longer term for MDT?
Would you make any other changes for slow but reliable growth and higher end of dividends.
As always, thank you for the great service.

Read Answer Asked by Tulio on August 21, 2025